CSIMarket
 

Dicerna Pharmaceuticals Inc   (DRNA)
Other Ticker:  
 

Dicerna Pharmaceuticals Inc 's Working Capital Per Sales

DRNA's Working Capital and Revenue growth



DRNA Working Capital Per Revenue (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Working Capital Change -9.84 % -3.31 % -13.77 % 40.16 % 92.94 %
Y / Y Revenue Change 28.81 % 2.2 % 39.89 % 478.47 % 508.28 %
Working Capital Per Revenue 2.09 2.31 2.34 2.63 3.07
Total Ranking # 3373 # 3487 # 3451 # 3692 # 3572
Seq. Working Capital Change -14.46 % -0.85 % -6.45 % 13.63 % -8.27 %
Seq. Revenue Change 52.29 % -13.16 % 16.23 % -16.2 % 20.83 %





Comment on DRNA's Working Capital Per Revenue in the third quarter 2021
Dicerna Pharmaceuticals Inc 's Working Capital Per Revenue in the Q3 2021 sequentially fell to 2.09 a new company low.

Within Healthcare sector 59 other companies have achieved lower Working Capital Per Revenue during the Q3 2021. While Dicerna Pharmaceuticals Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2021 to 3373, from total ranking in the second quarter 2021 at 3487.
Working Capital Per Revenue Ranking
Within: No.
Industry # 23
Sector # 60
S&P 500 # 3373


Working Capital Per Revenue Statistics
High Average Low
98.45
20.24
2.09
(Jun 30 2017)   (Sep 30 2021)



Financial Statements
Dicerna Pharmaceuticals Inc 's Working Capital $ 350 Millions Visit DRNA's Balance sheet
Dicerna Pharmaceuticals Inc 's Revenues $ 63 Millions Visit DRNA's Income Statement
Where are DRNA's Sales coming from? Visit DRNA's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2021, within Healthcare Sector Working Capital Per Revenue
Navidea Biopharmaceuticals Inc   5.73 
Liquidia Corporation  5.45 
Homology Medicines Inc  5.43 
G1 Therapeutics Inc   5.39 
Catheter Precision Inc   5.38 
Surgalign Holdings Inc   5.16 
Aravive Inc   5.15 
Ocular Therapeutix Inc   5.15 
Guardant Health Inc   5.12 
Opgen inc   5.11 
Revance Therapeutics Inc   5.04 
Perspective Therapeutics Inc   5.03 
Molecular Templates inc   5.02 
Electrocore Inc   4.97 
Schrodinger Inc   4.70 
Vyne Therapeutics Inc   4.68 
Aurinia Pharmaceuticals Inc   4.67 
Deciphera Pharmaceuticals Inc   4.59 
Castle Biosciences Inc   4.52 
Chemocentryx Inc.  4.50 
Sutro Biopharma Inc   4.45 
Ngm Biopharmaceuticals Inc   4.39 
Transmedics Group Inc   4.37 
Jaguar Health inc   4.13 
Theravance Biopharma inc   4.12 
Twist Bioscience Corporation  4.10 
Guardion Health Sciences Inc   4.09 
Avalo Therapeutics Inc   4.05 
Sangamo Therapeutics Inc   3.97 
Dariohealth Corp   3.95 
Date modified: 2023-03-22T16:50:07+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com